Andreas Persidis ^UDM

Dr. Andreas Persidis serves as the Co-founder and CEO of Biovista Inc., playing a pivotal role in developing the company's vision and establishing its position as a leader in systematic drug repositioning and Augmented Intelligence within the life sciences industry. Dr. Persidis actively contributes to new product development, forges strategic collaborations, and shapes Biovista's industry sectors. He is a member of the European Innovation Council, an expert advisor to the European Commission and the Austrian government, and the President of the Hellenic BioCluster (HBio). With a background in managing technology development teams in various fields, including engineering, software, and telecoms, Dr. Persidis brings extensive expertise to Biovista. The company specializes in delivering custom drug repositioning, drug de-risking, and clinical hold solutions for the Biopharma Industry. Additionally, Biovista develops powerful platform technologies for Life Science and Biotechnology companies, with an ongoing R&D program dedicated to innovation and improvement.